Brief: Lidds Updates On Clinical Program For Liproca Depot

Lidds AB

30/03/2021 07:32

March 30 (Reuters) - Lidds AB  LIDDS.ST :
    * LIDDS UPDATES ON THE CLINICAL PROGRAM FOR LIPROCA DEPOT
    * IS CONTINUING ITS WORK TO SELECT LICENSEES IN OTHER
MARKETS THAT
WILL SUPPORT AND SHARE COST IN SUCH A PHASE III MULTICENTER
STUDY
    * IT IS RECOMMENDED THAT CLINICS IN CHINA PARTICIPATE IN AN
INTERNATIONAL MULTICENTER STUDY
    * LIDDS AND JIANGXI PUHENG PHARMA HAS DECIDED TO PLAN A
MULTICENTER PHASE III STUDY
    * AIM IS TO LAUNCH PHASE III STUDY IN 2022
    * WILL PROVIDE FURTHER DETAILS ON PHASE III STUDY DESIGN AND
TIME
PLANS AFTER FURTHER REGULATORY INTERACTIONS

Source text for Eikon:  ID:nGNE5q6W4C 
Further company coverage:  LIDDS.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))